GE Healthcare CEO aims to grow from within

As head of business development at General Electric Co., John Flannery logged more than $26 billion in deals. But such an approach is far from his mind as CEO of the GE's healthcare unit.

Flannery wants to grow from within, even after revenue from diagnostic-imaging machines slowed. The company offers a wide range of products and services, including ventilators, software and tools to support drug manufacturing.

"When we look at the basic position of the company, we like the portfolio," Flannery said in an interview in Beijing. "So my mandate right now is to get the earnings growth going again, and there’s a lot to just better managing the portfolio we have, align it more with customers and outcomes, for a better margin rate."

Read more by following the link below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."